These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 5744295

  • 21. [Chronic obstructive bronchopneumopathy with evolutive character in cystic fibrosis].
    Rigillo N, Masciale A, Manca A.
    Arch Monaldi Mal Torace; 1989; 44(1-3):277-85. PubMed ID: 2520575
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical and bacteriological evaluation of minocycline in mucoviscidosis in children].
    Gilly R, Fougerat J.
    Poumon Coeur; 1974; 30(5):375-82. PubMed ID: 4469905
    [No Abstract] [Full Text] [Related]

  • 23. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M, Héritier F, Rappaz I, Schaad UB.
    Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
    [No Abstract] [Full Text] [Related]

  • 24. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
    Cahen P, Le Bourgeois M, Delacourt C, Coustère C, Nicaise P, de Blic J, Véron M, Scheinmann P, Gaillard JL.
    Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
    [Abstract] [Full Text] [Related]

  • 25. [Respiratory manifestations of mucoviscidosis].
    Hennequet A.
    Ann Pediatr (Paris); 1983 May; 30(5):358-67. PubMed ID: 6870111
    [No Abstract] [Full Text] [Related]

  • 26. Cystic fibrosis: a case report.
    Mo-Suwan L, Chungpanich S.
    J Med Assoc Thai; 1981 Dec; 64(12):630-5. PubMed ID: 6153031
    [No Abstract] [Full Text] [Related]

  • 27. [A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
    Reineri P, Squinazi F, Tobelem R, Lemerle S, Lobut JB, Bernaudin F, Kohout G, Bouveret.
    Pediatrie; 1984 Dec; 39(7):597-8. PubMed ID: 6598489
    [No Abstract] [Full Text] [Related]

  • 28. [Antibacterial therapy in lower respiratory tract infections].
    Mar Molinero F, Ramos Amador JT, Sánchez Díaz JI.
    An Esp Pediatr; 1997 Jun; Spec No 2():207-8. PubMed ID: 9382308
    [No Abstract] [Full Text] [Related]

  • 29. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
    Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML, Tirelli S, Calori G, Copreni E, Conese M.
    Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
    [Abstract] [Full Text] [Related]

  • 30. [Cystic fibrosis: current therapy. Inhalation antibiotics].
    Mordasini C.
    Schweiz Med Wochenschr Suppl; 2000 Jul; 122():43S-44S. PubMed ID: 12536472
    [No Abstract] [Full Text] [Related]

  • 31. Antibiotic therapy in cystic fibrosis.
    Med Lett Drugs Ther; 1969 Feb 21; 11(4):14-5. PubMed ID: 5375095
    [No Abstract] [Full Text] [Related]

  • 32. [Anti-infectious therapy in cystic fibrosis].
    Otto HS.
    Med Welt; 1974 Feb 15; 25(7):252-5. PubMed ID: 4816688
    [No Abstract] [Full Text] [Related]

  • 33. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
    Michalsen H, Bergan T.
    Scand J Infect Dis Suppl; 1981 Feb 15; 29():92-7. PubMed ID: 6947408
    [Abstract] [Full Text] [Related]

  • 34. To the editor: Alcaligenes as a pathogen in airways chronic infection in cystic fibrosis.
    Romano L, Bellodi S, Lugani F, Manno G.
    Pediatr Pulmonol; 2003 May 15; 35(5):412-3. PubMed ID: 12687601
    [No Abstract] [Full Text] [Related]

  • 35. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN, Ratjen F.
    Semin Respir Crit Care Med; 2009 Oct 15; 30(5):587-95. PubMed ID: 19760546
    [Abstract] [Full Text] [Related]

  • 36. [Oral antibiotic therapy in current practice: lower respiratory tract infections in children].
    Agence Française de Sécurité des Produits de Santé.
    Therapie; 2002 Oct 15; 57(1):76-81. PubMed ID: 12090152
    [No Abstract] [Full Text] [Related]

  • 37. [Respiratory deterioration and allergic bronchopulmonary aspergillosis in cystic fibrosis].
    Salcedo Posadas A.
    Enferm Infecc Microbiol Clin; 2000 Oct 15; 18(6):301-3. PubMed ID: 11075497
    [No Abstract] [Full Text] [Related]

  • 38. Management of the child with cystic fibrosis.
    Byrne S, David TJ.
    Br J Hosp Med; 2000 Oct 15; 50(8):445-51. PubMed ID: 8275282
    [Abstract] [Full Text] [Related]

  • 39. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH, McCracken GH.
    Pediatr Infect Dis J; 1988 May 15; 7(5):331-9. PubMed ID: 3288947
    [No Abstract] [Full Text] [Related]

  • 40. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
    Javadpour S, Jones A, Brownlee K.
    Ir Med J; 2007 May 15; 100(7):529-32. PubMed ID: 17886526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.